InsidersTradesSigma
Track the Q-linea AB (publ) share price and the full insider trade history of the company, a listed issuer based in Finland. Shares trade on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Q-linea AB (publ) has published 2 public disclosures. Market capitalisation: €311.7m. The latest transaction was disclosed on 11 June 2025 (Purchase). Among the most active insiders: Stuart Gander. Every trade is openly available.
2
Insider Decl.
n/a
Thresholds
€19,051
2 ops.
Buy Volume
n/a
n/a
Sell Volume
29Σ signal
Fundamental score
Ranked 28,743 of 28,803 companies
3.4
score / 100
Value4
Quality3
FCF yld-51%
Earn yld-55%
EV/EBITDA·
ROE-76%
Gross mgn-15%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 June 2025
Declarations2 total
2,500,000 shares@ €0.00470.0039% mcap61.9% of flowAktieISIN SE0011527845FI:A003P626-1
40,000,000 shares@ €0.00020.0024% mcap38.1% of flowOptionFI:A003O534-1
2 of 2 declarations
About Q-linea AB (publ)
Q-linea AB (publ) is a Swedish company focused on developing rapid diagnostic solutions for infections. It is listed on the Stockholm Stock Exchange (XSTO).